Start for free
Start for free
ADAR1 Capital Management logo

ADAR1 Capital Management

Description

ADAR1 Capital Management is an investment firm.

Investor Profile

ADAR1 Capital Management has made 8 investments, with 7 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (75%)
  • Series C (13%)
  • Series A (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Medical
  • Genetics
  • Robotics
  • Pharmaceutical
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ADAR1 Capital Management frequently co-invest with?

BP
BVF Partners
North America, California, United States, San Francisco
Co-Investments: 1
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 2
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners
North America, California, United States, Palo Alto
Co-Investments: 1
SB
Co-Investments: 1
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
VC
Velan Capital
North America, Georgia, United States, Alpharetta
Co-Investments: 1
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
SC
Stonepine Capital Management
North America, Oregon, United States, Bend
Co-Investments: 2
VP
Co-Investments: 1
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3

What are some of recent deals done by ADAR1 Capital Management?

Bambusa Therapeutics

Boston, Massachusetts, United States

Bambusa Therapeutics operates as biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series AFeb 14, 2025
Amount Raised: $90,000,000
Monopar

Wilmette, Illinois, United States

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

BiopharmaBiotechnologyDeveloper ToolsHealth CareOncologyTherapeutics
Post Ipo EquityDec 20, 2024
Amount Raised: $40,000,000
Palvella Therapeutics

Wayne, Pennsylvania, United States

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

BiotechnologyHealth CareLife ScienceTherapeutics
Post Ipo EquityDec 13, 2024
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Inhibikase Therapeutics

Atlanta, Georgia, United States

Inhibikase Therapeutics is a developer of cellular Abelson tyrosine kinase inhibitors to treat infections and other diseases.

Health CareHealth DiagnosticsTherapeutics
Post Ipo EquityOct 9, 2024
Amount Raised: $110,000,000
Tenax Therapeutics

Chapel Hill, North Carolina, United States

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 6, 2024
Amount Raised: $100,000,000
Kala Pharmaceuticals

Waltham, Massachusetts, United States

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityJun 27, 2024
Amount Raised: $12,500,000
iBio

Newark, Delaware, United States

iBio is a technology platform that develops pharmaceutical product applications.

BiotechnologyGeneticsRoboticsTherapeutics
Post Ipo EquityMar 26, 2024
Amount Raised: $15,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator